AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
Absence of slowest oscillations in short term heart rate variability of post-myocardial infarction patients. GISSI-3 arrhythmias substudy
Authors: Nollo, G Del Greco, M Disertori, M Santoro, E Maggioni, AP Sanna, GP
Citation: G. Nollo et al., Absence of slowest oscillations in short term heart rate variability of post-myocardial infarction patients. GISSI-3 arrhythmias substudy, AUTON NEURO, 90(1-2), 2001, pp. 127-131
Evidence and perspectives on n-3 polyunsaturated fatty acids in cardiovascular disease - Proceedings of the "Consensus Meeting: Clinical effect, Biological Background, and Research Priorities on n-3 Fatty acids", Research Centre of the Italian National Association of Hospital Cardiologists (ANMCO),Florence, Italy, 17-19 February 2000 - Executive summary
Authors: Marchioli, R Tognoni, G Barringer, TD Bhatnagar, D Berry, EM Burr, M De Caterina, R Harris, W Kromhout, D Lands, W Leaf, A Maggioni, AP Nordoy, A Simopoulos, A von Shacky, C Singh, RB Siscovick, D Tavazzi, L Valagussa, F
Citation: R. Marchioli et al., Evidence and perspectives on n-3 polyunsaturated fatty acids in cardiovascular disease - Proceedings of the "Consensus Meeting: Clinical effect, Biological Background, and Research Priorities on n-3 Fatty acids", Research Centre of the Italian National Association of Hospital Cardiologists (ANMCO),Florence, Italy, 17-19 February 2000 - Executive summary, EUR H J SUP, 3(D), 2001, pp. D1-D3
Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heart failure
Authors: Maggioni, AP Tavazzi, L Marchioli, R Tognoni, G Avanzini, F Roncaglioni, MC
Citation: Ap. Maggioni et al., Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heart failure, EUR H J SUP, 3(D), 2001, pp. D106-D109
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data
Authors: Pizzetti, F Turazza, FM Franzosi, MG Barlera, S Ledda, A Maggioni, AP Santoro, L Tognoni, G
Citation: F. Pizzetti et al., Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data, HEART, 86(5), 2001, pp. 527-532
Treatment strategies for heart failure: beta blockers and antiarrhythmics
Authors: Maggioni, AP
Citation: Ap. Maggioni, Treatment strategies for heart failure: beta blockers and antiarrhythmics, HEART, 85(1), 2001, pp. 97-103
Cardiac protection by pharmacological modulation of inflammation
Authors: Latini, R Masson, S Bertini, R Maggioni, AP Ghezzi, P Calvillo, L
Citation: R. Latini et al., Cardiac protection by pharmacological modulation of inflammation, EXPERT OP I, 10(11), 2001, pp. 1913-1924
Left ventricular mass and cardiovascular morbidity in essential hypertension: The MAVI study
Authors: Verdecchia, P Carini, G Circo, A Dovellini, E Giovannini, E Lombardo, M Solinas, P Gorini, M Maggioni, AP
Citation: P. Verdecchia et al., Left ventricular mass and cardiovascular morbidity in essential hypertension: The MAVI study, J AM COL C, 38(7), 2001, pp. 1829-1835
The consequences of under-use of coronary revascularization - Results of acohort study in Northern Italy
Authors: Filardo, G Maggioni, AP Mura, G Valagussa, F Valagussa, L Schweiger, C Ballard, DJ Liberati, A
Citation: G. Filardo et al., The consequences of under-use of coronary revascularization - Results of acohort study in Northern Italy, EUR HEART J, 22(8), 2001, pp. 654-662
Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure - The OSCUR study
Authors: Bellotti, R Badano, LP Acquarone, N Griffo, R Lo Pinto, G Maggioni, AP Mattiauda, C Menardo, G Mombelloni, P
Citation: R. Bellotti et al., Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure - The OSCUR study, EUR HEART J, 22(7), 2001, pp. 596-604
Assessment of absolute risk of death after myocardial infarction by use ofmultiple-risk-factor assessment equations - GISSI-Prevenzione mortality risk chart
Authors: Marchioli, R Avanzini, F Barzi, F Chieffo, C Di Castelnuovo, A Franzosi, MG Geraci, E Maggioni, AP Marfisi, RM Mininni, N Nicolosi, GL Santini, M Schweiger, C Tavazzi, L Tognoni, G Valagussa, F
Citation: R. Marchioli et al., Assessment of absolute risk of death after myocardial infarction by use ofmultiple-risk-factor assessment equations - GISSI-Prevenzione mortality risk chart, EUR HEART J, 22(22), 2001, pp. 2085-2103
Precipitating factors and decision-making processes of short-term worsening heart failure despite "Optimal" treatment (from the IN-CHF registry)
Authors: Opasich, C Rapezzi, C Lucci, D Gorini, M Pozzar, F Zanelli, E Tavazzi, L Maggioni, AP
Citation: C. Opasich et al., Precipitating factors and decision-making processes of short-term worsening heart failure despite "Optimal" treatment (from the IN-CHF registry), AM J CARD, 88(4), 2001, pp. 382-387
The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) trial
Authors: Pfeffer, MA Domanski, M Verter, J Dunlap, M Flaker, GC Gersh, B Hsia, J Goldberg, AD Limacher, MC Maggioni, AP Rosenberg, Y Rouleau, JL Warnica, JW Wasserman, AG Braunwald, E
Citation: Ma. Pfeffer et al., The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) trial, AM HEART J, 142(3), 2001, pp. 375-377
Heterogeneity of left ventricular remodeling after acute myocardial infarction: Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy
Authors: Giannuzzi, P Temporelli, PL Bosimini, E Gentile, F Lucci, D Maggioni, AP Tavazzi, L Badano, L Stoian, I Piazza, R Heyman, I Levantesi, G Cervesato, E Geraci, E Nicolosi, GL
Citation: P. Giannuzzi et al., Heterogeneity of left ventricular remodeling after acute myocardial infarction: Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy, AM HEART J, 141(1), 2001, pp. 131-138
Secondary prevention: improving outcomes following myocardial infarction
Authors: Maggioni, AP
Citation: Ap. Maggioni, Secondary prevention: improving outcomes following myocardial infarction, HEART, 84, 2000, pp. I5-I7
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin - Systematic overview of individual data from 96,712 randomized patients
Authors: Latini, R Tognoni, G Maggioni, AP Baigent, C Braunwald, E Chen, ZM Collins, R Flather, M Franzosi, M Kjekshus, J Kober, L Liu, LS Peto, R Pfeffer, M Pizzetti, F Santoro, E Sleight, P Swedberg, K Tavazzi, L Wang, W Yusuf, S
Citation: R. Latini et al., Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin - Systematic overview of individual data from 96,712 randomized patients, J AM COL C, 35(7), 2000, pp. 1801-1807
Electrocardiographic evolutionary changes and left ventricular remodeling after acute myocardial infarction - Results of the GISSI-3 Echo substudy
Authors: Bosimini, E Giannuzzi, P Temporelli, PL Gentile, F Lucci, D Maggioni, AP Tavazzi, L Badano, L Stoian, I Piazza, R Heyman, I Levantesi, G Cervesato, E Geraci, E Nicolosi, GL
Citation: E. Bosimini et al., Electrocardiographic evolutionary changes and left ventricular remodeling after acute myocardial infarction - Results of the GISSI-3 Echo substudy, J AM COL C, 35(1), 2000, pp. 127-135
beta-adrenoceptor antagonists and antianginal drugs
Authors: Maggioni, AP Franzosi, MG Latini, R
Citation: Ap. Maggioni et al., beta-adrenoceptor antagonists and antianginal drugs, SIDE EFFECT, 23, 2000, pp. 206-213
Long-term safety of an early ACE-inhibitor treatment of patients with acute myocardial infarction: results of the 3 year follow-up period on 696 Swiss patients randomized to the ISIS-4 trial
Authors: Genoni, M Malacrida, R Sessa, F Siegrist, P Maggioni, AP Moccetti, T
Citation: M. Genoni et al., Long-term safety of an early ACE-inhibitor treatment of patients with acute myocardial infarction: results of the 3 year follow-up period on 696 Swiss patients randomized to the ISIS-4 trial, Z KARDIOL, 89(2), 2000, pp. 81-83
Spectral and bidirectional filters give different results for signal-averaged ECG analysis in patients with postmyocardial infarction
Authors: Nollo, G Del Greco, M Disertori, M Micciolo, R Maggioni, AP Santoro, E Sanna, GP
Citation: G. Nollo et al., Spectral and bidirectional filters give different results for signal-averaged ECG analysis in patients with postmyocardial infarction, J ELCARDIOL, 33(3), 2000, pp. 233-240
PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans
Authors: Peri, G Introna, M Corradi, D Iacuitti, G Signorini, S Avanzini, F Pizzetti, F Maggioni, AP Moccetti, T Metra, M Dei Cas, L Ghezzi, P Sipe, JD Re, G Olivetti, G Mantovani, A Latini, R
Citation: G. Peri et al., PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans, CIRCULATION, 102(6), 2000, pp. 636-641
Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy - The randomized evaluation of strategies for left ventricular dysfunction pilot study
Authors: Cirillo, W Decanini, R Coelho, OR Avezum, A Peixoto, MSP Piegas, LS Neto, JMR Paiva, M Carvalho, AC de Almeida, DR Fernandes, IML Malavasi, MC Pavanello, R Canesin, M Ishii, S Barretto, ACP Imrie, J Moore, R Woo, K Bernstein, V Mizgala, HF Mooney, S Hilbich, D Kuritzky, R Rupka, DW Blackwell, MM Breakwell, L Kornder, JM Pearce, SA Polasek, P Richardson, PM Grant, J Isaac, D Beresford, P Giannoccaro, P Roth, D Greenwood, P Muzyka, T Prosser, A Brass, N Hui, W Kvill, L Goeres, M MacDonald, K Senaratne, M Hill, L Humen, D Teo, KK Habib, N Habib, N Teekasingh, S MacKenzie, J McEwen, B Morris, A Dhair, A Lai, C Kwiatkowski, K Brugos, J Nawaz, S Andrews, J Moe, G Freskiw, K Gilbert, B Morgan, CD Bozek, B Halperin, F Ricci, AJ Singh, N Cappelli, G Boyne, T Fallen, E Panju, A Woodcock, G Kent, E Kitching, AD Sullivan, H Tomson, D McKelvie, RS Tsuyuki, RT Yusuf, S Chan, YK Thomson, D Arnold, JMO Hurwitz, G Miles, R Baker, A Haspect, A Smith, S Bedard, J Lavoie, L Dufort, L Harvey, R Lepage, S Elstein, E Fitchett, D Serpa, A Day, L Racine, N Savard, D Sestier, F Gosselin, G Rouleau, JL White, M Whittom, L Kiwan, G Kouz, SM Laforest, M Ouimet, H Carmichael, P Lenis, J Auger, P Grondin, F Saulnier, D Campeau, J Dupuis, R Lauzon, C Genest, M Robitaille, NM Beaudoin, J Belanger, N Houde, G Talbot, P Cossett, J Koilpillai, C Sheridan, WJ Tobin, M Sussex, B Ascoli, G Fraticelli, A Paciaroni, E Como, CO Belluschi, R Ruffa, F Tettamanti, F Cobelli, F Salvucci, F Arpesella, R Campana, C Gavazzi, A Cirrincione, V Ingrilli, F Sciortino, E Boccanelli, A Cacciatore, G Menichelli, M Bosimini, E Giannuzzi, P Marcassa, C Porcu, M Salis, S Sanna, A Comerio, G Gronda, E Mangiavacchi, M Moccetti, T Pasotti, E Sessa, F Levy, WC Probstfield, J Thompson, J Gramberg, M Grover, J Towery, D Ogunyankin, K Singh, BN Celano, J Graham, S Kohn, RM Pande, P Sass, A Wiener, RS Rydzinski, S Starling, RC Young, J Hays, L Naftilan, A Miller, A Varga, A Wofford, R Barnhill, S Brito, RD Harris, L Haspect, A Cristina, T Jarosz, M Kellen, J Kingry, C Letterer, R La Forge, D Liuni, C MacKenzie, J Magi, A Stevens, K Squires, P Yusuf, S Rouleau, JL Maggioni, A Arnold, JMO Avezum, A Burns, R Floras, J Gavazzi, A Held, P Hjalmarson, A Isaac, D Latini, R Lindgren, E McKelvie, RS Piegas, LS Pericak, D Pogue, J Probstfield, J Smith, S Swedberg, K Teo, KK Tsuyuki, RT Vint-Reed, C Wang, Y White, M Wiecek, EM Young, J Johnstone, D Armstrong, PW Packer, M Wedel, H Teo, KK Gavazzi, A Tsuyuki, RT White, M McKelvie, R Anderson, M Holadyk-Gris, I Kucemba, K MacKay, J McKelvie, RS Micks, M Pericak, D Pogue, J Reeve, S Robinson, L Tsuyuki, RT Tucker, J Wiecek, EM Wang, Y Yusuf, S Cernacek, P Joyal, M Poitras, N Rouleau, JL White, M Sirois, P Bevilacqua, M Latini, R Masson, S Torri, M Hall, C Burns, RJ Heeney, T Tadros, S White, M Yusuf, S McKelvie, RS Pericak, D Young, J Latini, R Pogue, J Burns, RJ Probstfield, J Tsuyuki, RT Maggioni, AP Avezum, A Rouleau, JL
Citation: W. Cirillo et al., Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy - The randomized evaluation of strategies for left ventricular dysfunction pilot study, CIRCULATION, 101(4), 2000, pp. 378-384
Comparison of one-year outcome in women versus men with chronic congestiveheart failure
Authors: Opasich, C Tavazzi, L Lucci, D Gorini, M Albanese, MC Cacciatore, G Maggioni, AP
Citation: C. Opasich et al., Comparison of one-year outcome in women versus men with chronic congestiveheart failure, AM J CARD, 86(3), 2000, pp. 353
Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design
Authors: Pfeffer, MA McMurray, J Leizorovicz, A Maggioni, AP Rouleau, JL Van de Werf, F Henis, M Neuhart, E Gallo, P Edwards, S Sellers, MA Velazquez, E Califf, R
Citation: Ma. Pfeffer et al., Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design, AM HEART J, 140(5), 2000, pp. 727-734
Epidemiologic study of use of resources in patients with unstable angina: The EARISA Registry
Authors: Maggioni, AP Schweiger, C Tavazzi, L Langiano, T Lucci, D Ramponi, C Repetto, F De Vita, C
Citation: Ap. Maggioni et al., Epidemiologic study of use of resources in patients with unstable angina: The EARISA Registry, AM HEART J, 140(2), 2000, pp. 253-263
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors
Authors: Granger, CB Ertl, G Kuch, J Maggioni, AP McMurray, J Rouleau, JL Stevenson, LW Swedberg, K Young, J Yusuf, S Califf, RM Bart, BA Held, P Michelson, EL Sellers, MA Ohlin, G Sparapani, R Pfeffer, MA
Citation: Cb. Granger et al., Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors, AM HEART J, 139(4), 2000, pp. 609-617
Risultati: 1-25 | 26-42